Biomolecules & Therapeutics is a prominent journal published by the Korean Society of Applied Pharmacology, dedicated to advancing knowledge in the fields of Biochemistry, Drug Discovery, Molecular Medicine, and Pharmacology. With an ISSN of 1976-9148 and an E-ISSN of 2005-4483, this journal serves as a vital platform for researchers and professionals to disseminate their findings from 2008 through 2024. Ranking in the Q2 category across multiple relevant fields, including Pharmacology and Drug Discovery, and consistently placing in the 60th to 70th percentiles in Scopus rankings, Biomolecules & Therapeutics exemplifies a commitment to high-quality research and scientific integrity. Although it operates on a traditional access model, readers can be assured of the journal's rigorous peer-review process, ensuring that published articles contribute meaningfully to ongoing discourse in pharmacological and biochemical research. Located in Seoul, South Korea, the journal stands at the forefront of innovation in healthcare, making it an essential resource for academics, students, and industry professionals alike.

Cell Chemical Biology, published by Cell Press, stands at the forefront of interdisciplinary research in the realms of biochemistry, molecular biology, and pharmacology. With a robust impact factor evident in its prestigious Q1 quartile rankings across multiple categories including Clinical Biochemistry and Drug Discovery for 2023, this journal serves as a critical platform for disseminating cutting-edge scientific discoveries. As an Open Access publication, it ensures that vital research is accessible to a wide audience, fostering collaborations and driving innovation in the life sciences. Based in the United States, and featuring publications from 2016 to 2024, Cell Chemical Biology invites researchers, professionals, and students alike to contribute to its mission of advancing knowledge through rigorous peer-reviewed articles that address both fundamental and applied aspects of chemical biology.

Chemical Biology & Drug Design, an esteemed publication by WILEY, serves as a vital platform for the dissemination of pioneering research in the interdisciplinary fields of biochemistry, drug discovery, molecular medicine, organic chemistry, and pharmacology. With a dedicated commitment to advancing the understanding of chemical interactions and drug development, this journal not only fosters innovation but also bridges the gap between theoretical research and practical applications. It boasts an impressive impact factor and is recognized in the 2023 category quartiles as Q3 in Biochemistry and Molecular Medicine, and Q2 in Drug Discovery, Organic Chemistry, and Pharmacology, indicating its relevance and influence in these crucial areas. The journal’s rankings across various Scopus categories further solidify its position as a reputable resource for researchers, professionals, and students striving to stay at the forefront of medicinal chemistry and drug design. While primarily traditional access-based, the journal's evolving scope from 2006 to 2024 ensures an ongoing contribution to essential scientific dialogue, making it an indispensable read for those committed to advancing health sciences.

IUBMB LIFE is a prestigious, peer-reviewed journal published by WILEY, dedicated to advancing the fields of biochemistry, molecular biology, and cell biology. With an impressive impact factor and consistently ranked in the Q1 and Q2 categories across multiple relevant disciplines—including Biochemistry, Genetics, and Clinical Biochemistry—this journal has established itself as a leading platform for disseminating innovative research and critical reviews that propel scientific discovery. The journal spans a converged publication period from 1999 to 2024, providing comprehensive insights into the dynamic landscape of biochemical research. Researchers, professionals, and students alike are invited to explore its Open Access options, ensuring that groundbreaking studies are accessible to a global audience. As it continues to shape the future of life sciences, IUBMB LIFE remains a vital resource for those seeking to enrich their understanding and contribute to these rapidly evolving fields.

ACS Chemical Biology is a premier journal published by the American Chemical Society, dedicated to advancing the understanding of the chemical underpinnings of biological systems. With an ISSN of 1554-8929 and a distinguished track record since its inception in 2006, this journal provides a vital platform for the dissemination of high-quality research in the realms of biochemistry and molecular medicine, achieving a prestigious Q1 ranking in these categories as of 2023. In an era where interdisciplinary approaches are crucial, ACS Chemical Biology fosters collaboration among chemists and biologists, reflecting a steadfast commitment to exploring the chemical processes that govern life. Although it does not operate under an open-access model, the journal maintains a rigorous peer-review process, ensuring the publication of influential studies that shape the future of chemical biology. With an increasing impact factor and a focus on innovative research, ACS Chemical Biology remains an authoritative resource for researchers, professionals, and students eager to engage with cutting-edge findings in this dynamic field.

Bioinformatics and Biology Insights is a premier open-access journal dedicated to advancing the frontiers of bioinformatics and biology. Published by SAGE Publications Ltd, this journal is a leading platform for disseminating high-quality research that integrates computational methods with biological insights. Since its inception in 2007, the journal has garnered significant recognition, reflecting its commitment to excellence, as evidenced by its impressive impact factor and a strong presence across multiple quartiles in applied mathematics, biochemistry, and computational sciences. With a rank of Q1 in both Applied Mathematics and Computational Mathematics and various other notable rankings in related fields, it serves as an essential resource for researchers, professionals, and students seeking cutting-edge knowledge and innovations. The journal's open-access model ensures that findings are readily available, fostering collaboration and advancement in this dynamic field. Through its comprehensive scope and rigorous peer-review process, Bioinformatics and Biology Insights continues to play a pivotal role in shaping the future of biological research and computational methodologies.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, published by Academic Press Inc Elsevier Science, stands as a leading periodical in the fields of biochemistry, biophysics, cell biology, and molecular biology. With an ISSN of 0006-291X and an E-ISSN of 1090-2104, this esteemed journal has been a pivotal platform for the dissemination of groundbreaking research since its inception in 1959, continuing to publish influential findings through at least 2024. It holds a commendable Q2 ranking in Biochemistry and Q1 status in Biophysics as of 2023, reflecting its high impact and relevance in the field, supported by its strong Scopus rankings—ranking #43 in Biophysics and maintaining a presence in the top quartiles of several related categories. Although it is not an open-access journal, it provides critical insights and essential data that cater to researchers, professionals, and students keen on advancing their understanding of complex biochemical and biophysical processes. Its significant contributions to the scientific community underscore the importance of this journal as a reference point for innovative research and collaborative discourse.

Russian Journal of Bioorganic Chemistry (ISSN: 1068-1620, E-ISSN: 1608-330X), published by MAIK Nauka/Interperiodica/Springer, serves as a vital resource for researchers and professionals in the fields of bioorganic chemistry, biochemistry, and organic chemistry. With a focus on the integration of organic chemistry principles with biological processes, this journal aims to disseminate significant findings and advancements from both theoretical and practical perspectives. Although currently not open access, the journal retains a dedication to high-quality, peer-reviewed content, contributing to its reputation within the academic community. The 2023 Scopus rankings position it within the Q4 category for both biochemistry and organic chemistry, indicating its critical niche within these disciplines amid a competitive landscape. Since its inception in 1996, the journal has continued to evolve, providing enriching insights and fostering collaborations among scholars and practitioners alike, with publication converging up to the year 2024. By exploring complex biomolecular interactions and the synthesis of biologically relevant compounds, the Russian Journal of Bioorganic Chemistry remains a significant platform for advancing knowledge and innovation in the life sciences.

BioImpacts, an esteemed journal published by Tabriz University of Medical Sciences & Health Services, is a prominent platform dedicated to advancing the fields of Biochemistry, Genetics, Molecular Biology, Medicine, and Pharmaceutical Science. Established in 2011, this Open Access journal ensures that vital research findings are freely accessible to the global academic community. With an impressive presence in the Scopus database, BioImpacts currently holds a Q2 quartile ranking in its respective categories, reflecting its contribution to scientific discourse and its importance as a critical resource for researchers and practitioners alike. The journal's dynamic scope encompasses a wide range of topics, highlighting innovative research that addresses contemporary challenges in health and disease. Operating out of Tabriz, Iran, BioImpacts is committed to fostering interdisciplinary collaboration and knowledge dissemination through their dedicated publication efforts, which span from 2011 to 2024. Researchers, professionals, and students are encouraged to explore the rich content and cutting-edge studies presented in this journal, making it an indispensable resource in the scientific community.

Current Opinion in Systems Biology is an esteemed academic journal published by ELSEVIER, focusing on the dynamic and interdisciplinary field of systems biology. Since its inception in 2017, the journal has made significant strides in disseminating cutting-edge research and innovative perspectives across various domains, including applied mathematics, biochemistry, and drug discovery. With an impressive impact factor reflecting its prominent position as a Q1 journal in multiple categories—including Applied Mathematics, Biochemistry, and Computer Science Applications—it serves as a vital resource for researchers, professionals, and students alike. The journal embraces a comprehensive approach to understanding complex biological systems, fostering a deeper insight into the interactions within biological and computational frameworks. This makes it an essential conduit for advancing knowledge and innovation in systems biology, facilitating the development of new methodologies that could lead to groundbreaking discoveries.